In vitro and in vivo assessment of herb drug interactions

Life Sciences

Volumn 78, Issue 18, 2006, Pages 2105-2115

  Venkataramanan, Raman ^a,b,c   Komoroski, Bernard ^a   Strom, Stephen ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Universigy of Pittsburgh   (United States)

Author keywords

Hepatocytes; Herb drug interaction; Microsomes; Milk thistle; St. John's wort

Indexed keywords

ADHYPERFORIN; AMANITIN; BIAPIGENIN; CARBON TETRACHLORIDE; CONJUGATED ESTROGEN; DOPAMINE; DRUG METABOLIZING ENZYME; FLUOXETINE; GALACTOSAMINE; HERBACEOUS AGENT; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; HYPERIN; ISOQUERCITRIN; NORADRENALIN; PARACETAMOL; PAROXETINE; PSEUDOHYPERICIN; QUERCETIN; QUERCITRIN; RUTOSIDE; SEROTONIN; SILYBUM MARIANUM EXTRACT; SILYMARIN; SIMVASTATIN; THIOACETAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN; XENOBIOTIC AGENT;

CONFERENCE PAPER; DEPRESSION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG INHIBITION; DRUG MARKETING; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERANCE; DRUG TRANSPORT; HUMAN; HYPERICUM PERFORATUM; IN VITRO STUDY; IN VIVO STUDY; INSOMNIA; LIVER DISEASE; LIVER PROTECTION; LIVER TOXICITY; NEUROLOGIC DISEASE; NONHUMAN; PRESCRIPTION; PROSTATE CANCER; SILYBUM MARIANUM; VALERIANA OFFICINALIS; VITAMIN SUPPLEMENTATION;

ANIMALS; CARRIER PROTEINS; DRUG INTERACTIONS; HUMANS; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; PLANT PREPARATIONS;

HYPERICUM PERFORATUM; SILYBUM; SILYBUM MARIANUM; VALERIANA; VALERIANA OFFICINALIS;

EID: 33644929029     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.12.021     Document Type: Conference Paper

References (81)

1. S.M. Ahmed, N.R. Banner, and S.W. Dubrey Low cyclosporin-A level due to Saint-John's-wort in heart transplant patients Journal of Heart and Lung Transplantation 20 2001 795
2. C.Y. Ang, L. Hu, T.M. Heinze, Y. Cui, J.P. Freeman, K. Kozak, W. Luo, F.F. Liu, A. Mattia, and M. DiNovi Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage Journal of Agricultural and Food Chemistry 52 20 2004 6156 6164
3. G. Arold, F. Donath, A. Maurer, K. Diefenback, S. Bauer, H.H. Henneicke-von Zepelin, M. Friede, and I. Roots No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract Planta Medica 71 2005 331 337
4. S. Beckmann-Knopp, S. Rietbrock, R. Weyhenmeyer, R.H. Bocker, K.T. Beckurts, W. Lang, M. Hunz, and U. Fuhr Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes Pharmacol Toxicol 86 2000 250 256
5. M. Blumenthal Herbs continue slide in mainstream market: sales down 14 percent HerbalGram 58 2003 71
6. Z. Cheng, G.R. Rios, C.D. King, B.L. Coffman, M.D. Green, B. Mojarrabi, P.I. Mackenzie, and T.R. Tephly Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7 Toxicological Sciences 45 1998 52 57
7. V.J. Chrungoo, R.K. Reen, K. Singh, and J. Singh Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to d-galactosamine toxicity Indian Journal of Experimental Biology 35 1997 256 263
8. V.J. Chrungoo, K. Singh, and J. Singh Silymarin mediated differential modulation of toxicity induced by carbon tetrachloride, paracetamol and d-galactosamine in freshly isolated rat hepatocytes Indian Journal of Experimental Biology 35 1997 611 617
9. M.H. Court, S.X. Duan, L.L. von Moltke, D.J. Greenblatt, C.J. Patten, J.O. Miners, and P.I. Mackenzie Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms Journal of Experimental Biology 299 2001 998 1006
10. G. Cowley, P. King, M. Hager, and D. Rosenberg Going mainstream Newsweek 125 1995 56 57
11. F.A. Crocenzi, J.M. Pellegrino, E.J. Sanchez Pozzi, A.D. Mottino, E.A. Garay, and M.G. Roma Effect of silymarin on biliary bile salt secretion in the rat Biochemical Pharmacology 59 2000 1015 1022
12. F.A. Crocenzi, E.J. Sanchez Pozzi, J.M. Pellegrino, C.O. Favre, E.A. Rodriguez Garay, A.D. Mottino, R. Coleman, and M.G. Roma Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets Hepatology 34 2001 329 339
13. F.A. Crocenzi, E.J. Sanchez Pozzi, J.M. Pellegrino, E.A. Rodriguez Garay, A.D. Mottino, and M.G. Roma Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat Biochemical Pharmacology 66 2003 355 364
14. Y. Cui, C.Y. Ang, R.D. Beger, T.M. Heinze, L. Hu, and J. Leakey In vitro metabolism of hyperforin in rat liver microsomal systems Drug Metabolism and Disposition 32 2004 28 34
15. P.M. Dewick The biosynthesis of C5-C25 terpenoid compounds National Productivity Report 14 1997 111 144
16. R. DiCenzo, M. Shelton, K. Jordan, C. Koval, A. Forrest, R. Reichman, and G. Morse Coadministration of milk thistle and indinavir in healthy subjects Pharmacotherapy 23 7 2003 866 870
17. D. Durr, B. Stieger, G.A. Kullak-Ublick, K.M. Rentsch, H.C. Steinert, P.J. Meier, and K. Fattinger St John's Wort Induces Intestinal P-glycoprotein/MDR1 and Intestinal and Hepatic CYP3A4 2000 598 604
18. D.M. Eisenberg, R.B. Davis, S.L. Ettner, S. Appel, S. Wilkey, M. Van Rompay, and R.C. Kessler Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey JAMA 280 1998 1569 1575
19. K.N. Faber, M. Muller, and P.L. Jansen Drug transport proteins in the liver Advanced Drug Delivery Reviews 55 2003 107 124
20. Foster Steven, Tyler Varro, E., 1999. Tyler's honest herbal: a sensible guide to the use of herbs and related remedies. xxi, 442 pp.
21. S. Fournel-Gigleux, L. Sutherland, N. Sabolovic, B. Burchell, and G. Siest Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures Molecular Pharmacology 39 1991 177 183
22. R.F. Frye, S.M. Fitzgerald, T.F. Lagattuta, M.W. Hruska, and M.J. Egorin Effect of St John's wort on imatinib mesylate pharmacokinetics Clinical Pharmacology and Therapeutics 76 2004 323 329
23. R. Gebhardt, J.G. Hengstler, D. Muller, R. Glockner, P. Buenning, B. Laube, E. Schmelzer, M. Ullrich, D. Utesch, N. Hewitt, M. Ringel, B.R. Hilz, A. Bader, A. Langsch, T. Koose, H.J. Burger, J. Maas, and F. Oesch New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures Drug Metabolism Reviews 35 2003 145 213
24. T. Gerloff, B. Stieger, B. Hagenbuch, J. Madon, L. Landmann, J. Roth, A.F. Hofmann, and P.J. Meier The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver Journal of Biological Chemistry 273 1998 10046 10050
25. Gibson, G., Gordon, Skett Paul. 2001. Introduction to drug metabolism. viii, 256 pp.
26. B.J. Gurley, S.F. Gardner, M.A. Hubbard, D.K. Williams, W.B. Gentry, J. Carrier, I.A. Khan, D.J. Edwards, and A. Shah In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto Clinical Pharmacology and Therapeutics 76 5 2004 428 440 (Erratum in: Clinical Pharmacology and Therapeutics 2005 May;77(5):456)
27. Y.H. Han, H.X. Lou, D.M. Ren, L.R. Sun, B. Ma, and M. Ji Stereoselective metabolism of silybin diastereoisomers in the glucuronidation process Journal of Pharmaceutical and Biomedical Analysis 34 2004 1071 1078
28. K.A. Hoffmaster, R.Z. Turncliff, E.L. LeCluyse, R.B. Kim, P.J. Meier, and K.L. Brouwer P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide Pharmaceutical Research 21 2004 1294 1302
29. B.P. Jacobs, C. Dennehy, G. Ramirez, J. Sapp, and V.A. Lawrence Milk thistle for the treatment of liver disease: a systematic review and meta-analysis American Journal of Medicine 113 2002 506 515
30. S.J. Karpen, A.Q. Sun, B. Kudish, B. Hagenbuch, P.J. Meier, M. Ananthanarayanan, and F.J. Suchy Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter Journal of Biological Chemistry 271 1996 15211 15221
31. D.W. Kaufman, J.P. Kelly, L. Rosenberg, T.E. Anderson, and A.A. Mitchell Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey JAMA 287 2002 337 344
32. R.C. Kessler, R.B. Davis, D.F. Foster, M.I. Van Rompay, E.E. Walters, S.A. Wilkey, T.J. Kaptchuk, and D.M. Eisenberg Long-term trends in the use of complementary and alternative medical therapies in the United States Annals of Internal Medicine 135 2001 262 268
33. K. Koike, T. Kawabe, T. Tanaka, S. Toh, T. Uchiumi, M. Wada, S. Akiyama, M. Ono, and M. Kuwano A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells Cancer Research 57 1997 5475 5479
34. Komoroski, B.J., 2005. The direct and indirect effects of herbal products on common drug metabolizing enzymes and drug transporters. University of Pittsburgh, Pittsburgh. Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy.
35. B.J. Komoroski, S. Zhang, H. Cai, J.M. Hutzler, R. Frye, T.S. Tracy, S.C. Strom, T. Lehmann, C.Y. Ang, Y.Y. Cui, and R. Venkataramanan Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures Drug Metabolism and Disposition 32 2004 512 518
36. B.J. Komoroski, R.A. Parise, M.J. Egorin, S.C. Strom, and R. Venkataramanan Effect of St John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures Clinical Cancer Research 11 19 Pt1 2005 6972 6979 (Oct 1)
37. J. Konig, A.T. Nies, Y. Cui, I. Leier, and D. Keppler Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance Biochimica et Biophysica Acta 1461 1999 377 394
38. J. Konig, Y. Cui, A.T. Nies, and D. Keppler Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide Journal of Biological Chemistry 275 2000 23161 23168
39. V.E. Kostrubsky, S.C. Strom, J. Hanson, E. Urda, K. Rose, J. Burliegh, P. Zocharski, H. Cai, J.F. Sinclair, and J. Sahi Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats Toxicological Sciences 76 2003 220 228
40. H. Kouzuki, H. Suzuki, B. Stieger, P.J. Meier, and Y. Sugiyama Characterization of the transport properties of organic anion transporting polypeptide 1 (oatp1) and Na(+)/taurocholate cotransporting polypeptide (Ntcp): comparative studies on the inhibitory effect of their possible substrates in hepatocytes and cDNA-transfected COS-7 cells Journal of Pharmacology and Experimental Therapeutics 292 2000 505 511
41. G.A. Kullak-Ublick, M.G. Ismair, B. Stieger, L. Landmann, R. Huber, F. Pizzagalli, K. Fattinger, P.J. Meier, and B. Hagenbuch Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver Gastroenterology 120 2001 525 533
42. P. Letteron, G. Labbe, C. Degott, A. Berson, B. Fromenty, M. Delaforge, D. Larrey, and D. Pessayre Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant Biochemical Pharmacology 39 1990 2027 2034
43. K. Linde, G. Ramirez, C.D. Mulrow, A. Pauls, W. Weidenhammer, and D. Melchart St John's wort for depression-an overview and meta-analysis of randomised clinical trials BMJ 313 1996 253 258
44. X. Liu, J.P. Chism, E.L. LeCluyse, K.R. Brouwer, and K.L. Brouwer Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats Drug Metabolism and Disposition 27 1999 637 644
45. O. Luttringer, F.P. Theil, T. Lave, K. Wernli-Kuratli, T.W. Guentert, and A. de Saizieu Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes Biochemical Pharmacology 64 2002 1637 1650
46. M.K. Ma, and H.L. McLeod Lessons learned from the irinotecan metabolic pathway Current Medicinal Chemistry 10 2003 41 49
47. I. Mai, S. Bauer, E.S. Perloff, A. Johne, B. Uehleke, B. Frank, K. Budde, and I. Roots Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction Clinical Pharmacology and Therapeutics 76 2004 330 340
48. R. Meech, and P.I. Mackenzie Structure and function of uridine diphosphate glucuronosyltransferases Clinical and Experimental Pharmacology and Physiology 24 1997 907 915
49. E. Mills, K. Wilson, M. Clarke, B. Foster, S. Walker, B. Rachlis, N. DeGroot, V.M. Montori, W. Gold, E. Phillips, S. Myers, and K. Gallicano Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis European Journal of Clinical Pharmacology 61 1 2005 1 7 (Epub 2005 Jan 22)
50. L.B. Moore, B. Goodwin, S.A. Jones, G.B. Wisely, C.J. Serabjit-Singh, T.M. Willson, J.L. Collins, and S.A. Kliewer St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proceedings of the National Academy of Science USA 97 2000 7500 7502
51. P. Morazzoni, A. Montalbetti, S. Malandrino, and G. Pifferi Comparative pharmacokinetics of silipide and silymarin in rats European Journal of Drug Metabolism and Pharmacokinetics 18 1993 289 297
52. M. Mourelle, P. Muriel, L. Favari, and T. Franco Prevention of CCL4-induced liver cirrhosis by silymarin Fundamental & Clinical Pharmacology 3 1989 183 191
53. P. Muriel, T. Garciapina, V. Perez-Alvarez, and M. Mourelle Silymarin protects against paracetamol-induced lipid peroxidation and liver damage Journal of Applied Toxicology 12 1992 439 442
54. P. Nathan The experimental and clinical pharmacology of St John's wort (Hypericum perforatum L.) Molecular Psychiatry 4 1999 333 338
55. L. Nelson, and J. Perrone Herbal and alternative medicine Emergency Medicine Clinics of North America 18 2000 709 722
56. R.S. Obach Inhibition of human cytochrome P450 enzymes by constituents of St. John's wort, an herbal preparation used in the treatment of depression Journal of Pharmacology and Experimental Therapeutics 2000 88 95
57. R.P. Oude Elferink, D.K. Meijer, F. Kuipers, P.L. Jansen, A.K. Groen, and G.M. Groothuis Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport Biochimica et Biophysica Acta 1241 1995 215 268
58. S.C. Piscitelli, A.H. Burstein, D. Chaitt, R.M. Alfaro, and J. Falloon Indinavir concentrations and St John's wort Lancet 355 2000 547 548
59. A. Radominska-Pandya, P.J. Czernik, J.M. Little, E. Battaglia, and P.I. Mackenzie Structural and functional studies of UDP-glucuronosyltransferases Drug Metabolism Reviews 31 1999 817 899
60. A.P. Rafferty, H.B. McGee, C.E. Miller, and M. Reyes Prevalence of complementary and alternative medicine use: state-specific estimates from the 2001 Behavioral Risk Factor Surveillance System American Journal of Public Health 92 2002 1598 1600
61. J.F. Rodriguez-Landa, and C.M. Contreras A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts Phytomedicine 10 2003 688 699
62. S. Ruetz, and P. Gros Phosphatidylcholine translocase: a physiological role for the mdr2 gene Cell 77 1994 1071 1081
63. H. Schriewer, R. Badde, G. Roth, and H.M. Rauen The anti-hepatotoxic effect of silymarin on thioacetamide-induced liver damage Arzneimittelforschung 23 Suppl: 160 1973
64. E.G. Schuetz, K.N. Furuya, and J.D. Schuetz Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms Journal of Pharmacology and Experimental Therapeutics 275 1995 1011 1018
65. Schulz Volker, Hèansel Rudolf, Tyler Varro, E., 2001. Rational phytotherapy: a physician's guide to herbal medicine. xix, 383 pp.
66. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, and F.P. Guengerich Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians Journal of Pharmacology and Experimental Therapeutics 270 1994 414 423
67. A.J. Smith, J.L. Timmermans-Hereijgers, B. Roelofsen, K.W. Wirtz, W.J. van Blitterswijk, J.J. Smit, A.H. Schinkel, and P. Borst The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice FEBS Letters 354 1994 263 266
68. A.J. Smith, A. van Helvoort, G. van Meer, K. Szabo, E. Welker, G. Szakacs, A. Varadi, B. Sarkadi, and P. Borst MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping Journal of Biological Chemistry 275 2000 23530 23539
69. R.S. Solecki Shanidar IV, a Neanderthal flower burial in northern Iraq Science 190 1975 880 881
70. C. Sridar, T.C. Goosen, U.M. Kent, J.A. Williams, and P.F. Hollenberg Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases Drug Metabolism and Disposition 32 2004 587 594
71. S.C. Strom, L.A. Pisarov, K. Dorko, M.T. Thompson, J.D. Schuetz, and E.G. Schuetz Use of human hepatocytes to study p450 gene induction 1996 388 401
72. R.H. Tukey, and C.P. Strassburg Human UDP-glucuronosyltransferases: metabolism, expression, and disease Annual Review of Pharmacology and Toxicology 40 2000 581 616
73. R.H. Tukey, C.P. Strassburg, and P.I. Mackenzie Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity Molecular Pharmacology 62 2002 446 450
74. R. Venkataramanan, V. Ramachandran, B.J. Komoroski, S. Zhang, P.L. Schiff, and S.C. Strom Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures Drug Metabolism and Disposition 28 2000 1270 1273
75. G. Vogel, B. Tuchweber, W. Trost, and U. Mengs Protection by silibinin against Amanita phalloides intoxication in beagles Toxicology and Applied Pharmacology 73 1984 355 362
76. H. Wagner Antihepatotoxic flavonoids Progress in Clinical and Biological Research 213 1986 545 558
77. D. Wheatley LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients-a controlled 6-week clinical trial Pharmacopsychiatry 30 Suppl 2 1997 77 80
78. Thomas F. Woolf Handbook of Drug Metabolism vol. xi 1999 596 pp.
79. H.G. Xie, and R.B. Kim St. John's wort associated drug interactions: short term inhibition and long term induction? Clinical Pharmacology and Therapeutics 78 2005 19 24
80. J. Zhao, and R. Agarwal Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention Carcinogenesis 20 1999 2101 2108
81. R. Zuber, M. Modriansky, Z. Dvorak, P. Rohovsky, J. Ulrichova, V. Simanek, and P. Anzenbacher Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities Phytother Research 16 2002 632 638